PHVS Market Cap History



Below is a table of the PHVS market cap history going back to 2/5/2021:

Date PHVS Market Cap
2/5/2021885.06M

Also see: PHVS Shares Outstanding History
and PHVS YTD Return
Mouse over chart for data details
2/5/2021
Pharvaris is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for rare diseases with unmet need, initially focused on angioedema and other bradykinin-mediated diseases. Co.'s first molecule, PHA121, is a small-molecule bradykinin B2-receptor antagonist for the treatment of hereditary angioedema, or HAE. PHA121 has been observed to be a potent inhibitor in vitro as assessed using human recombinant bradykinin B2 receptors (150 pM); ex vivo as studied against endogenous bradykinin B2 receptors in a human umbilical vein model (350 pM); and in vivo in the human bradykinin-challenge model (170 pM). We show 1 historical shares outstanding datapoints in our PHVS shares outstanding history coverage, used to compute PHVS market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing PHVS market cap history over the course of time is important for investors interested in comparing PHVS's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of PHVS versus a peer is one thing; comparing PHVS market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like PHVS can fluctuate over the course of history. With this page we aim to empower investors researching PHVS by allowing them to research the PHVS market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree PHVS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Pharvaris NV (PHVS) is categorized under the Miscellaneous sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

PHYS Market Cap History
PHYT Market Cap History
PIAI Market Cap History
PIC Market Cap History
PICC Market Cap History
PILL Market Cap History
PIPP Market Cap History
PLAO Market Cap History
PLAT Market Cap History
PLIN Market Cap History
More Miscellaneous companies »

 

PHVS Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.